Literature DB >> 12359200

Histopathological grading does not affect survival after R0 surgery for gastric cancer.

K Inoue1, Y Nakane, T Michiura, K Nakai, H Iiyama, M Sato, S Okumura, K Yamamichi, K Hioki.   

Abstract

AIM: It is unclear whether Histopathological Grading (UICC, TNM Classification) affects survival after resection for gastric cancer.
METHODS: To investigate the prognostic significance of Histopathological Grading after gastrectomy, 1455 patients who underwent gastric resection for gastric adenocarcinoma were reviewed.
RESULTS: The R0 (UICC, R Classification) resection rate was inversely correlated with the grade (86.5% for Grade 1, 79.7% for Grade 2 and 69.2% for Grade 3) and the R1 and R2 resection rates increased with the grade. The Histopathological Grading did not influence survival in the 1119 patients who underwent R0 resection (71.0% for Grade 1, 65.7% for Grade 2 and 66.7% for Grade 3). When multivariate analysis was performed for the 1119 cases undergoing R0 resection, the Histopathological Grading was not a determinant prognostic factor.
CONCLUSION: We conclude that the UICC Histopathological Grading affects R0 resection rates, but does not affect survival independently.

Entities:  

Mesh:

Year:  2002        PMID: 12359200     DOI: 10.1053/ejso.2002.1310

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer.

Authors:  Saleh M Abbas; M W Booth
Journal:  Langenbecks Arch Surg       Date:  2005-01-15       Impact factor: 3.445

2.  A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.

Authors:  Susanne Blank; Sivaramakrishna Rachakonda; Gisela Keller; Wilko Weichert; Florian Lordick; Rupert Langer; Christoph Springfeld; Thomas Bruckner; Karen Becker; Rajiv Kumar; Katja Ott
Journal:  BMC Cancer       Date:  2014-02-03       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.